These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37694982)

  • 1. N6-methyladenosine-induced METTL1 promotes tumor proliferation via CDK4.
    Zhang C; Cui Y
    Biol Chem; 2024 Mar; 405(3):217-228. PubMed ID: 37694982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-cancer analysis reveals the pro-oncogenic role of N6-methyladenosine (m6A)-regulated NTMT1 in head and neck squamous cell carcinoma.
    Zhao C; Yu M; Li Y
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23603. PubMed ID: 38014887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.
    Zhang M; Kan D; Zhang B; Chen X; Wang C; Chen S; Gao W; Yang Z; Li Y; Chen Y; Zhu S; Wen S; Niu Y; Shang Z
    J Exp Clin Cancer Res; 2023 Aug; 42(1):215. PubMed ID: 37599359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
    Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
    Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.
    Zhang Z; Fu J; Zhang Y; Qin X; Wang Y; Xing C
    BMC Gastroenterol; 2023 Jun; 23(1):217. PubMed ID: 37344779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL1-mediated tRNA m
    Du D; Zhou M; Ju C; Yin J; Wang C; Xu X; Yang Y; Li Y; Cui L; Wang Z; Lei Y; Li H; He F; He J
    J Exp Clin Cancer Res; 2024 May; 43(1):154. PubMed ID: 38822363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WDR4 promotes HCC pathogenesis through N
    Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
    Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression.
    Hua M; Zhai X; Chen Y; Yin D
    Pathol Res Pract; 2024 Aug; 260():155437. PubMed ID: 38959625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL3-modified lncRNA-MALAT1 regulates the molecular axis of miR-124-3p/CDK4 involved in Ewing's sarcoma.
    He F; Ren T; Tang X
    Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):193-197. PubMed ID: 37605570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL1-m
    Ying X; Liu B; Yuan Z; Huang Y; Chen C; Jiang X; Zhang H; Qi D; Yang S; Lin S; Luo J; Ji W
    Clin Transl Med; 2021 Dec; 11(12):e675. PubMed ID: 34936728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL1/FOXM1 promotes lung adenocarcinoma progression and gefitinib resistance by inhibiting PTPN13 expression.
    Peng W; Fu J; Zhou L; Duan H
    Cancer Med; 2024 Jul; 13(13):e7420. PubMed ID: 38967523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N
    Han H; Yang C; Ma J; Zhang S; Zheng S; Ling R; Sun K; Guo S; Huang B; Liang Y; Wang L; Chen S; Wang Z; Wei W; Huang Y; Peng H; Jiang YZ; Choe J; Lin S
    Nat Commun; 2022 Mar; 13(1):1478. PubMed ID: 35304469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation.
    Pandolfini L; Barbieri I; Bannister AJ; Hendrick A; Andrews B; Webster N; Murat P; Mach P; Brandi R; Robson SC; Migliori V; Alendar A; d'Onofrio M; Balasubramanian S; Kouzarides T
    Mol Cell; 2019 Jun; 74(6):1278-1290.e9. PubMed ID: 31031083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL1 promotes hepatocarcinogenesis via m
    Chen Z; Zhu W; Zhu S; Sun K; Liao J; Liu H; Dai Z; Han H; Ren X; Yang Q; Zheng S; Peng B; Peng S; Kuang M; Lin S
    Clin Transl Med; 2021 Dec; 11(12):e661. PubMed ID: 34898034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m7G Methyltransferase METTL1 Promotes Post-ischemic Angiogenesis via Promoting VEGFA mRNA Translation.
    Zhao Y; Kong L; Pei Z; Li F; Li C; Sun X; Shi B; Ge J
    Front Cell Dev Biol; 2021; 9():642080. PubMed ID: 34136476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
    Huang M; Long J; Yao Z; Zhao Y; Zhao Y; Liao J; Lei K; Xiao H; Dai Z; Peng S; Lin S; Xu L; Kuang M
    Cancer Res; 2023 Jan; 83(1):89-102. PubMed ID: 36102722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyltransferase like 3 enhances pinin mRNA stability through N
    He M; Jiang D; Xun A; Yang J; Luo Q; Wu H
    Exp Physiol; 2022 Nov; 107(11):1283-1297. PubMed ID: 35996844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homeobox-D 1 and FTO form a transcriptional-epigenetic feedback loop to promote head and neck cancer proliferation.
    Zhang C; Xie L; Lin Z
    Cell Biol Int; 2023 Dec; 47(12):1987-1998. PubMed ID: 37655555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.